Navigation Links
Avanir Pharmaceuticals Reports Fiscal 2011 Fourth Quarter and Year End Financial Results
Date:12/12/2011

ad cash, cash equivalents and investments in securities totaling $81.8 million, including cash and cash equivalents of $79.5 million and restricted investments in securities of $2.3 million.

Note to Investors: As previously announced, Avanir will hold a conference call to discuss fiscal 2011 full year financial results today, December 12, 2011, beginning at 1:30 p.m. Pacific Time. You can listen to this call by dialing 1-877-558-3407 for domestic callers or +1-706-679-1941 for international callers, and entering passcode 33791527. Those interested in listening to the conference call live via the internet may do so by visiting http://www.avanir.com.

About AVP-923AVP-923 is a combination of two well-characterized compounds: the active ingredient dextromethorphan hydrobromide (an uncompetitive NMDA receptor antagonist and sigma-1 receptor agonist) and low dose quinidine sulfate (a CYP2D6 enzyme inhibitor), which serves to increase the bioavailability of dextromethorphan. The dosage form of AVP-923 of 20 mg DM/10 mg Q capsules (twice daily) is approved by the FDA under the brand name NUEDEXTA® which is indicated for the treatment of pseudobulbar affect (PBA).

About NUEDEXTANUEDEXTA® is the first and only FDA-approved treatment for pseudobulbar affect (PBA). NUEDEXTA is an innovative combination of two well-characterized components; dextromethorphan hydrobromide (20 mg), the ingredient active in the central nervous system, and quinidine sulfate (10 mg), a metabolic inhibitor enabling therapeutic dextromethorphan concentrations. NUEDEXTA acts on sigma-1 and NMDA receptors in the brain, although the mechanism by which NUEDEXTA exerts therapeutic effects in patients with PBA is unknown.

NUEDEXTA is not approved for the treatment of central neuropathic pain.

NUEDEXTA Important Safety InformationNUEDEXTA can interact with other medications causing significant changes in blood lev
'/>"/>

SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Avanir Pharmaceuticals Announces Date of Fiscal 2011 Fourth Quarter and Year End Financial Results and Conference Call
2. Avanir Pharmaceuticals to Participate in Piper Jaffray Health Care Conference
3. Avanir Pharmaceuticals Announces EMA Acceptance of Marketing Authorization Application for NUEDEXTA
4. Avanir Pharmaceuticals Submits European Marketing Authorization Application for NUEDEXTA
5. Avanir Pharmaceuticals to Present Data at the 2011 American Congress of Rehabilitation Medicine/American Society for Neurorehabilitation Medicine Annual Conference
6. Avanir Pharmaceuticals to Participate in Two Investor Conferences
7. Avanir Pharmaceuticals to Present at Stifel Nicolaus Healthcare Conference
8. Avanir Pharmaceuticals Files Lawsuits Against Par and Actavis for Infringement of NUEDEXTA Patents
9. Avanir Pharmaceuticals Reports Fiscal 2011 Third Quarter Financial Results
10. Avanir Pharmaceuticals Announces Appointment of Dr. Joao Siffert as Senior Vice President Research and Development
11. Avanir Pharmaceuticals to Present at Two Investor Conferences in August
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... mayo de 2015 Dipexium Pharmaceuticals, ... farmacéutica de fase tardía centrada en el ... 0.8%), y colaboradores de investigación clínica, han ... el diseño innovador de los ensayos pivotales ... evalúan Locilex®, su nuevo péptido de antibiótico ...
(Date:5/22/2015)... 22, 2015 /CNW/ - More than fifty years ago, Thalidomide ... sickness in expectant mothers. Tragically, Thalidomide caused serious and permanent ... Support has been provided to survivors over the ... Canada in 1991 and settlements from drug ... legal obligation to provide support, we have a clear moral ...
(Date:5/22/2015)... May 22, 2015  Effective staffing of key ... recognition and success. Research and ... to provide pharmaceutical and biotech marketing managers with ... budget) that are being channeled into marketing operations ... managers can utilize this report to benchmark their ...
Breaking Medicine Technology:Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 2Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 3Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 4Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 5Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 6Statement from Minister Ambrose on Thalidomide 2Statement from Minister Ambrose on Thalidomide 3Effective Marketing Services Group Critical for Pharmaceutical Brand Recognition 2
... PARSIPPANY, N.J., Jan. 11 Survival of the fittest? ... not only what you know today, but what you need ... Whoever has the right insight and accurate forecasting skills will ... (and growing) market in the world, its sheer size also ...
... Calif., Jan. 11 Derycz Scientific (OTC Bulletin Board: DYSC), a ... of information from content publishers to enterprise customers and their constituents, ... the website of DDN ( Drug Discovery News ). ... is titled "Speeding the Path to FDA Approval in the Era ...
Cached Medicine Technology:Elite Pharma Insiders to Reveal Key Survival Strategies for Pharmaceutical Industry in 2010 2Derycz Scientific Featured In DDN (Drug Discovery News) 2Derycz Scientific Featured In DDN (Drug Discovery News) 3
(Date:5/22/2015)... DMG Productions announces the upcoming airing ... on Friday, May 29, 2015 at 7:30 a.m. ET ... this episode Innovations will explore Interstate Restoration, a company ... through disaster recovery and restoration. , Additionally, the series ... to develop and deliver training and education in the ...
(Date:5/22/2015)... New York, NY (PRWEB) May 22, 2015 ... of Multifamily Housing, Marc Zuluaga, has been selected by ... innovative engineering. The award winners are featured in the ... given to 40 building industry professionals age 40 and ... to the building community, as well as in other ...
(Date:5/22/2015)... A new program for the "In America" television ... Physical Therapy. , James Earl Jones will host ... physical therapy and discusses how the exercises can decrease ... of ailments and injuries. Physical therapists work with ... enhances daily activities such as house cleaning and shopping, ...
(Date:5/22/2015)... In efforts to offer full and robust resources ... stretches has been a large focus over the last ... Chunk Fitness envisions a mid-June launch of these resources. ... at a later point in time. The current resources ... , About the Company: Chunk Fitness was founded in ...
(Date:5/22/2015)... Aliso Viejo, CA (PRWEB) May 22, 2015 ... 30 editable lower thirds designed exclusively for Final Cut ... creatively compatible with any design. , Intuitive on-screen-controls ... each unique lower third. Reflections, colors, layouts, and much ... the Inspector window. , Pro3rd Impression ...
Breaking Medicine News(10 mins):Health News:New Episode of Innovations Airing Friday, May 29, 2015 Via Discovery Channel 2Health News:Steven Winter Associates’ Marc Zuluaga Earns Innovative Engineering Award 2Health News:Developers at Pixel Film Studios Release Pro3rd Impression for Final Cut Pro X. 2
... it,s an accepted treatment in adults as well as ... 1990 and 2002, off-label use of anticancer drugs in ... percent, and most of that off-label use was for ... a number of countries. , In off-label use, a ...
... Nutter to Continue in Role of Chairman of the ... today that Brian Concannon will be promoted to the,position ... Brad,Nutter in this role. Brian will also join the ... continue as Chairman and CEO until,April 2009 and thereafter ...
... 27 HLTH Corporation,(Nasdaq: HLTH ) announced today that ... shares of its common stock at a price per share,of ... the tender offer,represents approximately 43% of HLTH,s currently outstanding shares. ... on the NASDAQ,Global Select Market on October 24, 2008 was ...
... row, HireRight, a leader in on-demand employment background ... Deloitte’s prestigious Technology Fast 50 Program for Orange ... technology, media, telecommunications and life sciences companies in ... nation’s leading professional services organizations. Rankings are based ...
... no gastrointestinal, side effects for people who need the ... ... Oct. 27 Announced today at the American,Dietetic Association, ... both heme (protein-based iron) and non-heme,iron (plant-based iron) will ...
... Medicine and Relationships With Healthcare,Facilities Are Among the ... Oct. 27 Decision Resources, one of the,world,s ... and,healthcare issues, has made available for free on ... 10 highlights of the Indian pharmaceutical market,that are ...
Cached Medicine News:Health News:Most Off-Label Cancer Drug Use for Palliative Care 2Health News:Haemonetics Announces Promotion of Brian Concannon to CEO Effective April 2009 2Health News:Haemonetics Announces Promotion of Brian Concannon to CEO Effective April 2009 3Health News:HLTH Corporation Announces Commencement of Its Tender Offer 2Health News:HLTH Corporation Announces Commencement of Its Tender Offer 3Health News:HLTH Corporation Announces Commencement of Its Tender Offer 4Health News: HireRight Named to Deloitte Technology Fast 50 for the Sixth Year in a Row : Attributes Customer Focus and Innovative Screening Solutions to its 230 Percent Revenue Growth 2Health News: HireRight Named to Deloitte Technology Fast 50 for the Sixth Year in a Row : Attributes Customer Focus and Innovative Screening Solutions to its 230 Percent Revenue Growth 3Health News:First-Ever Over-the-Counter Dual Action Iron Supplement Launched at the American Dietetic Association Conference in Chicago; Bifera to be Available in Select Stores in Early 2009 2Health News:Top 10 Things Pharma Should Know About India - Free Paper From Decision Resources 2
Lambotte periosteal elevators....
Modified Freer periosteal elevator, #163, slight curve, 21 cm....
Williger periosteal elevator, 6 1/4", sharp, 5 mm wide....
Alley periosteal elevator, extra long, 21 cm, 8-1/4"....
Medicine Products: